NCT06942000View on ClinicalTrials.gov

Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions
Post Spinal Anesthesia Shivering
Interventions
DRUG

dexmedetomidine 3mcg group

3mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

dexmedetomidine 5mcg

5mcg of preservative-free dexmedetomidine in (0.5 ml) preservative-free 0.9% saline.

DRUG

preservative-free 0.9% saline.

(0.5 ml) preservative-free 0.9% saline

Trial Locations (2)

71523

Faculty of Medicine, Al-Azhar University, Assiut, Egypt, Asyut

Mohamed Ali Mahmoud, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER